Page last updated: 2024-11-06

floxuridine and Bone Neoplasms

floxuridine has been researched along with Bone Neoplasms in 38 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.

Research Excerpts

ExcerptRelevanceReference
"The effect of the combination treatment consisted of 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA) was investigated in 20 recurrent breast cancer patients."9.08[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient]. ( Hayashi, K; Taniguchi, T; Toi, M; Tominaga, T, 1995)
"Two cases of metastatic breast cancer are reported in which endocrine chemotherapy with Toremifene + 5'-DFUR proved markedly effective."7.70[Endocrine chemotherapy (high-dose toremifene + 5'-DFUR) found markedly effective for 2 cases of metastatic breast cancer]. ( Kuroda, T; Mizutani, H; Nakamura, Y; Tadaoka, N; Takahashi, N, 1999)
"Two cases of recurrent breast cancer are reported in which chemotherapy with mitoxantrone proved remarkably effective."7.70[Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer]. ( Katagata, N; Matsuoka, T; Nomizu, T; Takenoshita, S; Tsuchiya, A; Watanabe, F; Yabuta, T; Yamaki, Y, 2000)
"Although most patients with gestational trophoblastic neoplasia (GTN) are cured by conventional chemotherapy, some develop drug resistance or relapse."5.37Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia. ( Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y, 2011)
"Two patients were diagnosed as advanced breast cancer with multiple bone metastases."5.33[Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)]. ( Kihara, M; Kontani, K; Yamauchi, A; Yokomise, H, 2005)
"The effect of the combination treatment consisted of 5'-deoxy-5-fluorouridine (5'-DFUR) and medroxyprogesterone acetate (MPA) was investigated in 20 recurrent breast cancer patients."5.08[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient]. ( Hayashi, K; Taniguchi, T; Toi, M; Tominaga, T, 1995)
"A 42-year-old woman with multiple organ metastases from breast cancer was successfully treated with 5'-deoxy-5-fluorouridine (5'-DFUR) and hormonal therapy (leuprorelin+tamoxifen)."3.73[A case of recurrent breast cancer with multiple lung, adrenal, inferior vena cava tumor thrombus and bone metastases successfully treated with 5'-DFUR and hormonal therapy]. ( Fukami, Y; Hasegawa, H; Hiromatsu, T; Itazu, K; Kawai, K; Komatsu, S; Sakamoto, E; Tabata, T, 2005)
"Two cases of metastatic breast cancer are reported in which endocrine chemotherapy with Toremifene + 5'-DFUR proved markedly effective."3.70[Endocrine chemotherapy (high-dose toremifene + 5'-DFUR) found markedly effective for 2 cases of metastatic breast cancer]. ( Kuroda, T; Mizutani, H; Nakamura, Y; Tadaoka, N; Takahashi, N, 1999)
"Two cases of recurrent breast cancer are reported in which chemotherapy with mitoxantrone proved remarkably effective."3.70[Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer]. ( Katagata, N; Matsuoka, T; Nomizu, T; Takenoshita, S; Tsuchiya, A; Watanabe, F; Yabuta, T; Yamaki, Y, 2000)
"Growth inhibition assays indicated that the IC50 values for methotrexate (MTX) and 5-fluorodeoxyuridine (FdUrd) in HS-18, a liposarcoma cell line lacking retinoblastoma protein (pRB), and SaOS-2, an osteosarcoma cell line with a truncated and nonfunctional pRB, were 10- to 12-fold and 4- to 11-fold higher, respectively, than for the HT-1080 (fibrosarcoma) cell line, which has wild-type pRB."3.69Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines. ( Almasan, A; Banerjee, D; Bertino, JR; Fan, J; Hochhauser, D; Kelly, R; Li, W; Wahl, GM; Yin, Y; Zielinski, Z, 1995)
" Therapeutic safety was evaluated by analyses of adverse events with the recommended dose."2.72[Evaluation of safety and efficacy for bi-weekly Docetaxel and 5'-DFUR combination therapy in patients with advanced or recurrent breast cancer--Phase I study]. ( Ikeda, M; Ishiguro, K; Kataoka, T; Komaki, K; Kurebayashi, J; Morimoto, T; Sonoo, H; Tanaka, K; Tangoku, A; Yoshizawa, K, 2006)
" The purpose of the present study was to examine the efficacy of long-term administration of 5'-DFUR/CPA for patients with recurrent breast cancer."2.71The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer. ( Aihara, N; Fukunaga, M; Iba, T; Kidokoro, A; Suda, M; Sugiyama, K, 2004)
"Although most patients with gestational trophoblastic neoplasia (GTN) are cured by conventional chemotherapy, some develop drug resistance or relapse."1.37Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia. ( Feng, F; Geng, S; Wan, X; Wang, T; Xiang, Y, 2011)
"Gemcitabine was rapidly eliminated from plasma even in patients with renal dysfunction."1.35Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer. ( Hirobe, M; Itoh, T; Kunishima, Y; Masumori, N; Takayanagi, A; Takeuchi, M; Tsukamoto, T, 2008)
"Two patients were diagnosed as advanced breast cancer with multiple bone metastases."1.33[Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)]. ( Kihara, M; Kontani, K; Yamauchi, A; Yokomise, H, 2005)
" Two months later a side effect of MPA, her body weight gain, was observed, and the dosage of MPA was reduced from 1,200 mg/day to 800 mg/day."1.31[A case of long surviving advanced recurrent breast cancer with multiple bone metastases responding to treatment with 5'-DFUR combined with MPA]. ( Otsuka, T; Tashiro, S; Terashima, Y, 2002)
"We experienced 522 patients with breast carcinoma and 14 cases (2."1.29[A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy]. ( Matsumine, T; Matsumoto, J; Minami, T; Takami, M; Takanishi, K, 1996)
"However, metastatic bone tumors from gastric cancer usually resist any treatments."1.28[A case of gastric cancer with recurrent bone metastases successfully treated with induced hypertension chemotherapy using cisplatin]. ( Furuya, K; Kashu, Y; Kiyasu, Y; Moriuchi, A; Sakai, K; Satoh, H; Shigematsu, S; Tanaka, T, 1992)

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19904 (10.53)18.7374
1990's12 (31.58)18.2507
2000's20 (52.63)29.6817
2010's2 (5.26)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, F1
Xiang, Y1
Wan, X1
Geng, S1
Wang, T1
Kusama, M2
DOWD, JE1
DIPAOLO, JA1
WATNE, AL1
Tomono, H1
Kitamura, H1
Iwase, M1
Kuze, S1
Ohi, S1
Itoh, Y1
Nakazawa, H1
Fujita, H1
Oya, J1
Ishii, K1
Tsugawa, K1
Nakamura, M1
Ohnishi, I1
Miwa, K1
Iba, T2
Kidokoro, A2
Fukunaga, M2
Sugiyama, K2
Aihara, N2
Suda, M2
Suda, T1
Sakamoto, E1
Hasegawa, H1
Komatsu, S1
Hiromatsu, T1
Itazu, K1
Tabata, T1
Kawai, K1
Fukami, Y1
Kihara, M2
Kontani, K1
Yamauchi, A1
Yokomise, H1
Morin, KW1
Duan, W1
Knaus, EE1
McEwan, AJ1
Wiebe, LI1
Hiraga, T1
Hata, K1
Ikeda, F1
Kitagaki, J1
Fujimoto-Ouchi, K1
Tanaka, Y1
Yoneda, T1
Suzuki, S1
Sekikawa, K1
Fujita, S1
Abe, N1
Ishigame, T1
Okada, R1
Gonda, K1
Saito, M1
Onogi, H1
Ohki, S1
Takenoshita, S2
Ikeda, M1
Sonoo, H2
Tanaka, K1
Kurebayashi, J1
Morimoto, T2
Tangoku, A1
Komaki, K1
Kataoka, T1
Ishiguro, K1
Yoshizawa, K1
Masumori, N1
Kunishima, Y1
Hirobe, M1
Takeuchi, M1
Takayanagi, A1
Tsukamoto, T1
Itoh, T1
Barone, RM1
Byfield, JE1
Goldfarb, PB1
Frankel, S1
Ginn, C1
Greer, S1
Li, W1
Fan, J1
Hochhauser, D1
Banerjee, D1
Zielinski, Z1
Almasan, A1
Yin, Y1
Kelly, R1
Wahl, GM1
Bertino, JR1
Toi, M1
Taniguchi, T1
Hayashi, K1
Tominaga, T1
Takeshita, T1
Masuyama, H1
Shimizu, S1
Tanahasi, T1
Suzuki, H1
Toyama, T1
Matsumoto, J1
Minami, T1
Takami, M1
Takanishi, K1
Matsumine, T1
Matsusaka, K1
Miyauchi, A1
Maeda, M1
Fujitake, S1
Maeda, Y1
Shimizu, M1
Nozaki, H1
Tohyama, M1
Kataoka, S1
Senoo, T1
Nishiki, M1
Takashima, S1
Tadaoka, N1
Nakamura, Y1
Mizutani, H1
Kuroda, T1
Takahashi, N1
Kokufu, I2
Taniguchi, H2
Kim, YH2
Fukuda, K2
Yamamoto, M2
Yano, T2
Yamada, K2
Kitano, H2
Tanaka, R1
Fukushima, H1
Sato, K1
Matsuda, M1
Hanaoka, T1
Goya, T1
Oura, S1
Sakurai, T1
Yoshimura, G1
Tamaki, T1
Umemura, T1
Kokawa, Y1
Naito, Y1
Matsuoka, T1
Nomizu, T1
Yabuta, T1
Katagata, N1
Watanabe, F1
Yamaki, Y1
Tsuchiya, A1
Watanabe, Y1
Kaiga, T1
Ueda, T1
Fujii, M1
Fukuda, Y1
Hirao, S1
Koyama, I1
Takatori, H1
Terakura, M1
Mayumi, K1
Tsukazaki, Y1
Kinoshita, H1
Otsuka, T1
Terashima, Y1
Tashiro, S1
Miyamoto, H1
Yoshida, S1
Imatomi, M1
Saitoh, T1
Nakata, A1
Kaise, H1
Nakayama, S1
Ota, D1
Aoki, T1
Koyanagi, Y1
Misaka, T1
Matunaga, T1
Koh, J1
Murayama, Y1
Sano, M1
Katai, H1
Maeda, K1
Sakai, S1
Yamamoto, O1
Hashimoto, M1
Hosoda, Y1
Kiyasu, Y1
Kashu, Y1
Sakai, K1
Shigematsu, S1
Tanaka, T1
Furuya, K1
Moriuchi, A1
Satoh, H1
Hoshino, A1
Ohara, K1
Kamiya, O1
Nagata, K1
Ono, Y1
Kawakubo, A1
Ozaki, Y1
Suzuki, A1
Ogasawara, T1
Sugiura, I1
Reichman, BS1
Kemeny, NE1
Yeh, SD1

Trials

6 trials available for floxuridine and Bone Neoplasms

ArticleYear
The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
    International journal of clinical oncology, 2004, Volume: 9, Issue:5

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast

2004
[Evaluation of safety and efficacy for bi-weekly Docetaxel and 5'-DFUR combination therapy in patients with advanced or recurrent breast cancer--Phase I study].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:6

    Topics: Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Ne

2006
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; B

1995
[Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:7

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Adm

1999
[The efficacy of combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR), cyclophosphamide (CPA) and medroxyprogesterone acetate (MPA) for bone metastasis in breast cancer patients].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:7

    Topics: Adult; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Adm

2001
[Clinical trial of a new fluorinated pyrimidine, 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1

    Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Drug Admin

1986

Other Studies

32 other studies available for floxuridine and Bone Neoplasms

ArticleYear
Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Dru

2011
[Doxifluridine, medroxyprogesterone acetate and cyclophosphamide(DMpC)combination therapy found effective for case of chest wall recurrent breast cancer with bone and pleural metastases].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophospha

2012
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neop

1964
[A case of advanced breast cancer with multiple lung, bone and lymph node metastases successfully treated with 5'-DFUR alone].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:12

    Topics: Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy;

2003
[A case of breast cancer with lung and bone metastasis treated successfully by oral combination chemotherapy of 5'-deoxy-5-fluorouridine and cyclophosphamide].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal,

2003
[Effective reduction of elevated tumor markers by exemestane--a 12-year follow-up of a case of bone metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:3

    Topics: Aged; Androstadienes; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocol

2005
[A case of recurrent breast cancer with multiple lung, adrenal, inferior vena cava tumor thrombus and bone metastases successfully treated with 5'-DFUR and hormonal therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas

2005
[Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:5

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast

2005
A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2'-fluoro-2'-deoxyuridine.
    Nuclear medicine and biology, 2005, Volume: 32, Issue:5

    Topics: Bone Neoplasms; Cell Line, Tumor; Floxuridine; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; O

2005
Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model.
    Oncology reports, 2005, Volume: 14, Issue:3

    Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Capec

2005
[A case of recurrent gastric cancer effectively treated by combination chemotherapy of weekly paclitaxel and 5'- DFUR after showing resistance to weekly paclitaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:3

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Moda

2006
Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:3

    Topics: Antimetabolites, Antineoplastic; Area Under Curve; Bone Neoplasms; Cystectomy; Deoxycytidine; Fatal

2008
Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases.
    Cancer, 1982, Sep-01, Volume: 50, Issue:5

    Topics: Adult; Aged; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Colonic Neoplasms; Drug Admin

1982
Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Oct-24, Volume: 92, Issue:22

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Base Sequence; Bone Neoplasms; Cell Division

1995
[A case of long surviving inflammatory breast cancer with bone metastasis, treated by intra-arterial infusion chemotherapy followed by extended mastectomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:11

    Topics: Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Female; Floxuridine; Humans;

1993
[A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Femal

1996
[A case of stage IV breast cancer showing long-term complete response to combination therapy with 5'-DFUR and MPA].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13

    Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Ne

1998
[A case of giant advanced breast cancer responding remarkably to chemo-endocrine therapy chiefly with doxifluridine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, D

1998
[Endocrine chemotherapy (high-dose toremifene + 5'-DFUR) found markedly effective for 2 cases of metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Flox

1999
[A case of adriamycin and methotrexate-resistant recurrent breast cancer treated with doxifluridine and mitomycin C].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:9

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco

1999
[Successful endocrine chemotherapy in patients with multiple bone metastases of breast cancer--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality

1999
[Pain relief with alendronate therapy in a breast cancer patient with bone metastasis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:4

    Topics: Aged; Alendronate; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Ne

2000
[Chemotherapy with mitoxantrone for the treatment of recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administratio

2000
[A case of effective bisphosphonate therapy of sequential pamidronate and incadronate for bone metastases from breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Dr

2000
[A case of advanced breast cancer that responded remarkably to chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide;

2000
[Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report
    Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:2

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bre

2001
[A case of long surviving advanced recurrent breast cancer with multiple bone metastases responding to treatment with 5'-DFUR combined with MPA].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2

    Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bre

2002
[Successful treatment of advanced recurent breast cancer using DMpC therapy as maintenance therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophospha

2002
[A case of breast cancer with multiple bone metastases that responded remarkably to doxifluridine (5'-DFUR), cyclophosphamide (CPA), medroxyprogesterone acetate (MPA) and pamidronate disodium therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide;

2002
[A case of advanced breast cancer responding to low-dose 5'-DFUR].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:7

    Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female;

1992
[A case of gastric cancer with recurrent bone metastases successfully treated with induced hypertension chemotherapy using cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:9

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Bone and Bones

1992
A complication of prolonged infusional chemotherapy masquerading as a bone metastasis in a patient with colorectal carcinoma.
    Cancer, 1987, Mar-15, Volume: 59, Issue:6

    Topics: Adenocarcinoma; Adult; Bone Neoplasms; Catheterization; Floxuridine; Humans; Liver Neoplasms; Male;

1987